流感免疫规划项目成本效果的系统综述
本系统综述检索文献数据库和灰色文献,纳入41项流感免疫规划经济学评价研究,其中31项为高质量研究。从社会视角看,对儿童、孕妇及产后妇女、高危人群以及部分健康工作年龄成人接种具有成本效果;群体接种程序比个体接种程序更具成本效果。在实施针对性规划的地区,有必要重新评估「高危」标准并考虑普遍接种规划。
要点
- 对儿童、孕妇及产后妇女、高危人群接种流感疫苗具有成本效果。
- 群体接种程序比个体接种程序更具成本效果。
- 在针对性规划地区,有必要重新评估「高危」标准并考虑普遍规划。
核心结论
- 从社会视角看,对儿童、孕妇及产后妇女、高危人群以及部分健康工作年龄成人接种具有成本效果。
- 群体接种程序比个体接种程序更具成本效果。
- 在实施针对性规划的地区,有必要重新评估「高危」标准并考虑普遍接种规划。
研究设计与样本
- 系统综述检索文献数据库和灰色文献中的流感免疫规划经济学评价研究。
- 纳入研究使用苏格兰校际指南网络(SIGN)清单并补充WHO疫苗相关问题进行质量评价。
- 共纳入41项流感免疫研究,其中31项为高质量研究,提取高质量研究数据进行综述。
主要发现
- 孕妇及产后妇女:全部接种对比仅高危妇女接种,结果从优势(成本更低且更有效)到每获得1个QALY需9773美元(社会视角),以及从优势到每获得1个QALY需58000美元(医疗系统视角)。
- 儿童:全部接种对比仅高危儿童接种,结果从优势到每获得1个QALY需47000美元(社会视角),以及从优势到每获得1个QALY需18000美元(医疗系统视角)。
- 高危成人接种具有高度成本效果;医务人员接种结果为每获得1个QALY需35000美元。
- 健康工作年龄成人的结果不一,且对疫苗覆盖率、效力和生产力损失敏感。
关键数值与推荐
- 孕妇及产后妇女全部接种对比仅高危接种:社会视角从优势到每QALY 9773美元;医疗系统视角从优势到每QALY 58000美元。
- 儿童全部接种对比仅高危接种:社会视角从优势到每QALY 47000美元;医疗系统视角从优势到每QALY 18000美元。
- 高危成人接种具有高度成本效果;医务人员接种每QALY 35000美元。
- 健康工作年龄成人结果不一,对疫苗覆盖率、效力和生产力损失敏感。
临床怎么用
- 从社会视角看,对儿童、孕妇及产后妇女、高危人群以及部分健康工作年龄成人接种具有成本效果。
- 群体接种程序比个体接种程序更具成本效果。
- 在实施针对性规划的地区,有必要重新评估「高危」标准并考虑普遍接种规划。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Seasonal influenza immunization programs vary widely across jurisdictions. In Canada, some provinces offer universal programs while others target specific population groups. However, whether targeted or universal programs provide more benefit and value-for-money is unclear. The cost-effectiveness of influenza immunization programs was systematically reviewed to inform policy. METHODS: Citation databases and the grey literature were searched for economic evaluations of influenza immunization programs. Eligible studies were appraised using the Scottish Intercollegiate Guidelines Network (SIGN) checklist with supplemental WHO vaccine-related questions. Data from high quality studies was extracted and the studies reviewed. RESULTS: A total of 41influenza immunization studies were identified. Of these, 31 were high quality. For pregnant and postpartum women, vaccinating all versus only high risk women study results ranged from dominance (less costly and more effective) to $9773 per QALY gained (societal) and from dominance to $58,000 per QALY gained (healthcare system). Studies of vaccinating all versus only high risk children found vaccination to be dominant to $47,000 per QALY gained (societal), and dominant to $18,000 per QALY gained (healthcare system). Vaccinating high risk adults was highly cost-effective and vaccinating health care workers resulted in $35,000 per QALY gained. Results for healthy working adults were mixed and sensitive to vaccine uptake, efficacy, and productivity loss. CONCLUSIONS: From the societal perspective, vaccination was cost-effective for children, pregnant and postpartum women, high risk groups, and in some cases, healthy working age adults. Immunization programs using group administration are more cost-effective than programs using individual administration. The perspective, programmatic design, setting, and inclusion of herd immunity affects cost-effectiveness. In regions with targeted programs, re-evaluating "high risk" criteria and consideration of a universal program is warranted.
引用
- Ting EEK, Sander B, Ungar WJ, et al. Systematic review of the cost-effectiveness of influenza immunization programs. Vaccine. 2017. PMID: 28284681. doi:10.1016/j.vaccine.2017.02.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。